COM:INTELLIATX
Intellia Therapeutics
- Stock
Last Close
13.80
22/11 21:00
Market Cap
2.23B
Beta: -
Volume Today
2.41M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -9.57M - | -178.25M 1,762.04% | -203.35M 14.08% | -34.67M 82.95% | |||||||
average payables | 779.50K - | 3.01M 285.63% | 3.41M 13.51% | 2.44M 28.49% | 3.32M 36.25% | 7.20M 116.59% | 10.06M 39.66% | 7.40M 26.38% | 6.30M 14.86% | ||
average receivables | 500K - | 3.73M 645.40% | 8.46M 127.06% | 9.01M 6.46% | 6.08M 32.47% | 3.38M 44.52% | 2.08M 38.36% | 2.90M 39.37% | 20.11M 593.64% | ||
book value per share | 3.81 - | 9.44 147.63% | 8.35 11.59% | 6.45 22.71% | 5.71 11.48% | 9.41 64.81% | 14.67 55.86% | 16.05 9.40% | 11.83 26.30% | ||
capex per share | -0.14 - | -0.28 91.87% | -0.28 1.02% | -0.15 47.33% | -0.14 2.59% | -0.06 55.47% | -0.18 181.00% | -0.76 321.60% | |||
capex to depreciation | -7.79 - | -5.58 28.28% | -3.37 39.64% | -1.42 57.74% | -1.22 14.62% | -0.57 53.29% | -1.85 225.87% | -7.71 316.58% | |||
capex to operating cash flow | 1.45 - | -0.17 111.79% | 0.15 190.54% | 0.10 32.86% | 0.07 36.60% | 0.07 9.15% | 0.06 21.08% | 0.18 209.06% | |||
capex to revenue | -0.42 - | -0.37 11.47% | -0.39 3.28% | -0.21 45.93% | -0.16 24.55% | -0.06 60.78% | -0.39 524.31% | -1.12 190.28% | |||
cash per share | 4.29 - | 12.29 186.29% | 9.46 23.00% | 7.29 22.93% | 5.92 18.81% | 10.67 80.22% | 10.56 1.02% | 15.49 46.72% | 10.28 33.68% | ||
days of inventory on hand | |||||||||||
days payables outstanding | |||||||||||
days sales outstanding | 60.39 - | 142.95 136.71% | 146.34 2.37% | 90.51 38.15% | 39.12 56.78% | 13.41 65.73% | 22.43 67.30% | 26.39 17.65% | 366.82 1,290.16% | ||
debt to assets | 0.05 - | 0.06 5.72% | 0.06 1.60% | 0.09 50.36% | 0.09 3.12% | ||||||
debt to equity | 0.07 - | 0.07 9.53% | 0.07 4.58% | 0.11 48.66% | 0.11 3.83% | ||||||
dividend yield | |||||||||||
earnings yield | -0.03 - | -0.11 241.93% | -0.10 10.12% | -0.15 48.74% | -0.13 7.87% | -0.04 69.17% | -0.03 24.85% | -0.18 489.14% | -0.18 2.60% | ||
enterprise value | -9.85M - | 314.56M 3,295.11% | 18.27M 94.19% | 351.36M 1,823.51% | 529.04M 50.57% | 654.26M 23.67% | 2.92B 347.06% | 8.33B 184.90% | 2.29B 72.49% | 2.60B 13.19% | |
enterprise value over ebitda | -24.05 - | -0.57 97.64% | -5.05 789.34% | -5.82 15.25% | -6.49 11.51% | -21.42 229.88% | -31.11 45.27% | -5.16 83.43% | -5.39 4.60% | ||
ev to operating cash flow | -178.42 - | 0.51 100.28% | -5.38 1,164.04% | -8.64 60.45% | -6.34 26.62% | -58.60 824.73% | -37.03 36.81% | -6.88 81.42% | |||
ev to sales | 52.04 - | 1.11 97.87% | 13.45 1,113.68% | 17.38 29.21% | 15.18 12.68% | 50.44 232.27% | 252.11 399.87% | 43.99 82.55% | 71.54 62.64% | ||
free cash flow per share | -0.24 - | 1.35 651.36% | -2.09 255.34% | -1.57 25.00% | -2.33 48.35% | -0.96 58.97% | -3.35 251.02% | -5.09 51.71% | |||
free cash flow yield | -0.01 - | 0.10 1,029.44% | -0.11 205.96% | -0.12 5.61% | -0.16 38.03% | -0.02 88.94% | -0.03 61.50% | -0.15 414.14% | |||
graham net net | 3.50 - | 8.49 142.87% | 7.58 10.78% | 5.81 23.31% | 4.63 20.33% | 7.86 69.77% | 4.62 41.27% | 11.38 146.57% | 7.76 31.84% | ||
graham number | 7.76 - | 17.39 124.12% | 18.77 7.94% | 16.96 9.64% | 15.88 6.38% | 21.80 37.26% | 34.78 59.56% | 47.96 37.91% | 37.99 20.80% | ||
income quality | 0.14 - | -1.14 902.65% | 0.97 184.67% | 0.72 25.73% | 1.04 44.51% | 0.37 64.15% | 0.84 125.91% | 0.70 16.33% | |||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -53.64 - | ||||||||||
interest debt per share | 0.39 - | 0.70 80.51% | 1.04 48.73% | 1.81 73.26% | 1.30 28.17% | ||||||
inventory turnover | |||||||||||
invested capital | 0.07 - | 0.07 9.53% | 0.07 4.58% | 0.11 48.66% | 0.11 3.83% | ||||||
market cap | 390.37M - | 291.33M 25.37% | 692.04M 137.54% | 587.89M 15.05% | 693.11M 17.90% | 3.05B 339.42% | 8.38B 175.22% | 2.69B 67.96% | 2.71B 0.78% | ||
net current asset value | 7.00M - | 62.84M 797.50% | 192.17M 205.80% | 279.19M 45.28% | 255.58M 8.46% | 225.08M 11.93% | 448.12M 99.09% | 515.08M 14.94% | 932.27M 80.99% | 747.52M 19.82% | |
net debt to ebitda | 5.80 - | 8.49 46.50% | 4.90 42.32% | 0.65 86.78% | 0.39 40.48% | 0.88 129.27% | 0.18 79.14% | 0.88 379.12% | 0.23 73.79% | ||
net income per share | -0.70 - | -1.42 102.84% | -1.88 31.78% | -1.98 5.63% | -1.96 0.99% | -2.24 14.31% | -3.66 63.34% | -6.37 73.84% | -5.42 14.89% | ||
operating cash flow per share | -0.10 - | 1.62 1,728.05% | -1.81 211.57% | -1.42 21.55% | -2.19 53.63% | -0.89 59.20% | -3.17 256.05% | -4.33 36.41% | |||
payables turnover | |||||||||||
receivables turnover | 6.04 - | 2.55 57.75% | 2.49 2.31% | 4.03 61.68% | 9.33 131.36% | 27.23 191.84% | 16.27 40.23% | 13.83 15.00% | 1.00 92.81% | ||
research and ddevelopement to revenue | 1.85 - | 1.93 4.55% | 2.59 34.06% | 2.93 13.05% | 2.52 14.10% | 2.59 3.11% | 6.95 168.08% | 8.06 15.89% | 11.99 48.85% | ||
return on tangible assets | -0.15 - | -0.11 29.89% | -0.18 69.67% | -0.25 36.87% | -0.28 12.85% | -0.19 33.05% | -0.20 8.07% | -0.32 60.73% | -0.37 14.70% | ||
revenue per share | 0.34 - | 0.74 116.73% | 0.73 2.19% | 0.71 2.58% | 0.91 29.10% | 1.04 13.54% | 0.47 54.99% | 0.68 45.24% | 0.41 39.65% | ||
roe | -0.18 - | -0.15 18.09% | -0.22 49.05% | -0.31 36.66% | -0.34 11.85% | -0.24 30.64% | -0.25 4.80% | -0.40 58.91% | -0.46 15.49% | ||
roic | -0.18 - | -0.15 19.64% | -0.22 49.51% | -0.35 57.43% | -0.32 7.20% | -0.21 34.70% | -0.22 3.59% | -0.32 44.78% | -0.38 18.74% | ||
sales general and administrative to revenue | 1.37 - | 1.02 25.62% | 1.07 5.27% | 1.06 1.43% | 0.95 9.94% | 0.76 20.05% | 2.15 182.42% | 1.73 19.45% | 3.21 85.35% | ||
shareholders equity per share | 3.81 - | 9.44 147.63% | 8.35 11.59% | 6.45 22.71% | 5.71 11.48% | 9.41 64.81% | 14.67 55.86% | 16.05 9.40% | 11.83 26.30% | ||
stock based compensation to revenue | 0.22 - | 0.41 88.29% | 0.59 43.97% | 0.56 4.53% | 0.35 37.49% | 0.34 1.98% | 1.42 314.41% | 1.75 23.30% | |||
tangible asset value | 7.57M - | 67.36M 790.25% | 209.84M 211.53% | 300.60M 43.25% | 277.92M 7.54% | 269.88M 2.89% | 527.07M 95.30% | 1.04B 97.36% | 1.24B 18.78% | 1.05B 15.01% | |
tangible book value per share | 3.81 - | 9.44 147.63% | 8.35 11.59% | 6.45 22.71% | 5.71 11.48% | 9.41 64.81% | 14.67 55.86% | 16.05 9.40% | 11.83 26.30% | ||
working capital | 7.78M - | 66.93M 760.85% | 250.58M 274.38% | 323.47M 29.09% | 284.40M 12.08% | 253.85M 10.74% | 533.12M 110.01% | 643.47M 20.70% | 1.09B 69.43% | 883.12M 19.00% |
All numbers in USD (except ratios and percentages)